Home
About
Our Services
Contact

Life Sciences Legal Update

Analysis & commentary by Reed Smith on trends & developments in life sciences & health care law

Home Legislative Developments New Postings on the Reed Smith Health Industry Washington Watch Blog

New Postings on the Reed Smith Health Industry Washington Watch Blog

By Lisa Baird on 9 June 2009 Posted in Legislative Developments, Regulatory Developments

The Reed Smith Health Industry Washington Watch blog has been updated to discuss a variety of health policy developments, including the following:

FDA Transparency Task Force
Toll-Free Numbers for Adverse Events Reporting
Generic Drugs

Tweet this post Like this post Email this post Share this post on LinkedIn

Tags: cms Drugs, Drug Safety, Food and Drug Administration (FDA), Legislative Developments, Regulatory Developments

Stay Connected

Subscribe to this blog by Email

Your website url

Topics

Class Actions
Clinical Trials
Electronic Discovery
Employment & Labor
Health Care
Industry Developments
Industry Events
International Life Sciences
- EME Life Sciences
Legislative Developments
Life Sciences Legal Update Roundup
Privacy & HIPAA
Product Liability
Reed Smith Blogs
Regulatory Developments
Services
Uncategorized

Recent Updates

Life Sciences Legal Update News; A must-read for all subscribers
U.S. Court of Appeals rules AI cannot be named an inventor
FDA finalizes guidance on voluntary recalls, issues recommendations for industry
Join Us: Free CLE Webinar on the Best & Worst Drug/Medical Device Decisions of 2021
Health care workers and private employees could be affected by new CMS interim final rule and OSHA final rule

Newsfeed

Using TwIqbal To Require Plaintiffs To Identify Claimed Warning Inadequacy
Taxotere Lone Pine Continues to Stand
No Debating Pennsylvania’s Rejection of Strict Liability for Implantable Medical Devices
Drowsy Cold Medicine Consumer Fraud Case Sleepwalks Past Preemption
New California law to regulate automated claims processing using modern technology, like AI

Reed Smith Sites

AdLaw By Request
Antitrust and Competition Update
Asset Finance in Brief
EHS Law Insights
Employment Law Watch
Financial Services Litigation Report

Global Regulatory Enforcement Law Blog
Global Restructuring Watch
Health Industry Washington Watch
Legal Flight Deck
Life Sciences Legal Update
Policyholder Perspective
Real Estate Legal Update
Reed Smith
Ship Law Log
Structured Finance In Brief
Technology Law Dispatch

Archives

Archives

Other Links

Defense Research Institute
Drug and Device Law
Food and Drug Administration
Food and Drug Law Institute
HHS Office of Inspector General
SCOTUSBlog
TortsProf Blog
US Dept. of Health and Human Services
WSJ's Health Blog

© 2024, Reed Smith LLP. All Rights Reserved.

Law blog design & platform by LexBlog

Life Sciences Legal Update

Stay Connected

Privacy Policy |
Disclaimer

About Reed Smith LLP

Reed Smith represents many of the world's leading companies in complex litigation and other high-stakes disputes, cross-border and other strategic transactions, and crucial regulatory matters.

With lawyers from coast-to-coast in the United States, as well as in Europe, Asia and the Middle East, Reed Smith is known for its experience across a broad array of industry sectors.

LexBlog